Merck Kgaa (MRCG)

146.65 +1.10 (+0.76%)
Close EUR Disclaimer

MRCG Financial Summary

For the three months ended 31 March 2022, Merck KGaA revenues increased 12% to EUR5.2B. Net income applicable to common stockholders increased 18% to EUR880M. Revenues reflect Life Science segment increase of 15% to EUR2.45B, Healthcare segment increase of 10% to EUR1.8B, Asia Pacific (Region) segment increase of 12% to EUR1.89B, North America segment increase of 12% to EUR1.43B. Net income benefited from Finance costs decrease of 23% to EUR65M (expense).
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
MRCG
Gross margin TTM 59.23%
Operating margin TTM -
Net Profit margin TTM -
Return on Investment TTM -
Total Revenue
Net Income
Title
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Total Revenue 5,198 5,213 4,973 4,870
Gross Profit 3,211 3,254 3,114 3,057
Operating Income 1,173 1,039 1,047 1,049
Net Income 881 802 761 745
Clear All
0Selected
Please try another search
MRCG
Quick Ratio MRQ -
Current Ratio MRQ 1.42
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
Total Assets
Total Liabilities
Title
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Total Assets 46,235 45,362 43,836 43,145
Total Liabilities 23,316 24,024 23,229 23,852
Total Equity 22,919 21,338 20,607 19,293
Clear All
0Selected
Please try another search
MRCG
Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow 8.23%
Cash
Net Change in Cash
Title
Mar 31, 2022
Dec 31, 2021
Sep 30, 2021
Jun 30, 2021
Cash From Operating Activities 840 4,616 3,571 2,104
Cash From Investing Activities -1,089 -1,578 -1,226 -587
Cash From Financing Activities -315 -2,504 -2,184 -1,054
Net Change in Cash -560 543 168 469
Clear All
0Selected
Please try another search

* In Millions of (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles